CD8A and neoplasm: When analyzing the Tc2 transcription factor, GATA-3, we found 1.6 times upregulation in CD8+ T cells derived from SN (p<0.01) and 2 times upregulation in CD8+ T cells from tumor when compared to from PBMC (p<0.01) (Fig 4D).